Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Tettamanti

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Oncoimmunology|August 2, 2014
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?Sarah Tettamanti, Andrea Biondi, Ettore Biagi, et al.
Immunology Letters|October 1, 2013
Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectorsSarah Tettamanti, Chiara Francesca Magnani, Andrea Biondi, et al.
Leukemia|July 24, 2021
Catch me if you can: how AML and its niche escape immunotherapySarah Tettamanti, Alice Pievani, Andrea Biondi, et al.
International Journal of Molecular Sciences|October 16, 2025
Special Issue "The Promising Future of CAR-Based Therapies: A Matter of Molecular Details"Fabio Nicolini, Orsola Montini, Matteo Zurlo, et al.
Journal of Autoimmunity|August 28, 2017
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemiaAndrea Biondi, Chiara F Magnani, Sarah Tettamanti, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
CARs are sharpening their weaponsAlice Pievani, Marta Biondi, Sarah Tettamanti, et al.
Frontiers in Oncology|May 4, 2013
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectivesChiara F Magnani, Sarah Tettamanti, Francesca Maltese, et al.
Frontiers in Immunology|June 18, 2024
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapiesAntonio Maria Alviano, Marta Biondi, Erica Grassenis, et al.
International Journal of Molecular Sciences|January 11, 2025
Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical InterventionsMartina Maria Capelletti, Orsola Montini, Emilio Ruini, et al.
Cells|May 31, 2020
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?Chiara F Magnani, Sarah Tettamanti, Gaia Alberti, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Oncoimmunology|August 2, 2014
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?Sarah Tettamanti, Andrea Biondi, Ettore Biagi, et al.
Immunology Letters|October 1, 2013
Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectorsSarah Tettamanti, Chiara Francesca Magnani, Andrea Biondi, et al.
Leukemia|July 24, 2021
Catch me if you can: how AML and its niche escape immunotherapySarah Tettamanti, Alice Pievani, Andrea Biondi, et al.
International Journal of Molecular Sciences|October 16, 2025
Special Issue "The Promising Future of CAR-Based Therapies: A Matter of Molecular Details"Fabio Nicolini, Orsola Montini, Matteo Zurlo, et al.
Journal of Autoimmunity|August 28, 2017
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemiaAndrea Biondi, Chiara F Magnani, Sarah Tettamanti, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
CARs are sharpening their weaponsAlice Pievani, Marta Biondi, Sarah Tettamanti, et al.
Frontiers in Oncology|May 4, 2013
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectivesChiara F Magnani, Sarah Tettamanti, Francesca Maltese, et al.
Frontiers in Immunology|June 18, 2024
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapiesAntonio Maria Alviano, Marta Biondi, Erica Grassenis, et al.
International Journal of Molecular Sciences|January 11, 2025
Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical InterventionsMartina Maria Capelletti, Orsola Montini, Emilio Ruini, et al.
Cells|May 31, 2020
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?Chiara F Magnani, Sarah Tettamanti, Gaia Alberti, et al.
Pageof 4